Oscar Health Inc vs Vanguard Total World Stock Index Fund ETF — how do they compare? Oscar Health Inc trades at $32.91 (market cap $10.22B), while Vanguard Total World Stock Index Fund ETF trades at $159.57 (market cap $101.70B). The key difference: Vanguard Total World Stock Index Fund ETF is far larger — about 10× Oscar Health Inc's market cap, and Oscar Health Inc is more actively traded (4,123,394 versus 1,783,794). Which is the better fit depends on your goals — on Pluang, investors hold Oscar Health Inc for 15 Days and Vanguard Total World Stock Index Fund ETF for 53 Days on average.
| OSCR | VT | |
|---|---|---|
Market Cap | $10.22B | $101.70B |
Volume | 4,123,394 | 1,783,794 |
Sector | Health | Broad Market / Factor |
52-Week High | $33.81 | $162.39 |
52-Week Low | $10.85 | $134.19 |
Typical Hold Time | 15 Days | 53 Days |
Enterprise Value | $6.57B | — |
Signals from Pluang's Aura AI — not financial advice
OSCR trades at $33.05, up 0.43% today, with strong technical momentum indicated by bullish moving averages. The company shows impressive growth with Q1 and Q2 2026 EPS beats and projected 2026 revenue of $15.3B. Valuation metrics appear reasonable with P/S of 0.63 and EV/EBITDA of 7.79, while profitability metrics show significant improvement from 2025 losses to projected 2026 net income of $551M.
The outlook remains positive with analyst consensus at $34.00 target and Strong Buy ratings from Zacks. Key opportunities include ACA market share gains and margin expansion, while risks center on rising medical costs and execution of growth targets. The stock faces near-term resistance at $34 with RSI suggesting potential overbought conditions.
VT, the Vanguard Total World Stock ETF, trades at $159.39, down 0.16% on the day. Technical indicators show a bearish bias with moving averages signaling selling pressure, while oscillators remain neutral. The ETF offers broad global diversification with over 9,700 stocks and a low expense ratio of 0.06%, though key valuation ratios like P/E and P/B are not disclosed in the provided data. Recent news highlights its role as a core holding for long-term investors seeking worldwide exposure.
The outlook for VT is supported by its cost efficiency and diversification benefits, but near-term technical weakness and competitive pressures from lower-fee alternatives pose risks. Investor sentiment is mixed, with some analysts favoring VT for its comprehensive coverage, while others point to higher expenses relative to peers. Macroeconomic uncertainties and trade tensions could impact global equity returns, affecting VT's performance.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Oscar Health, Inc. is a health insurance company that utilizes a technology-driven approach to simplify the healthcare experience. The company offers individual, small-group, and Medicare Advantage plans, primarily through a platform that integrates technology, data, and design to provide members with a personalized, efficient healthcare journey. Oscar aims to lower costs and improve engagement by focusing on consumer-centricity and modernizing the traditional health insurance model.
Read more on OSCR →VT is a foundational, low-cost ETF that seeks to track the FTSE Global All Cap Index, providing exposure to nearly 10,000 stocks across developed and emerging markets worldwide, including the United States. It serves as a single-ticker solution for total global equity diversification, capturing approximately 98% of the world's investable market capitalization.
Read more on VT →